Fiche centre
Vanderbilt University Medical Center
Nashville — United States
Essais liés47clinical trials
VilleNashvillelocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06211764
Essais cliniques associés
47| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Capstan Compass Robotic System for Transcatheter Mitral Valve Replacement | Maladie coronarienne | Non applicable | NCT07917208 | Early Feasibility Study of the Capstan Medical TMVR System | RECRUITING |
| Evolocumab | Maladie coronarienne | Phase 4 | NCT05284747 | EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction | ACTIVE_NOT_RECRUITING |
| Hearo App | Insuffisance cardiaque | À vérifier | NCT06378632 | DETECT-HF — AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM | COMPLETED |
| Selatogrel | Maladie coronarienne | Phase 3 | NCT04957719 | SOS-AMI — Selatogrel Outcome Study in Suspected Acute Myocardial Infarction | ENROLLING_BY_INVITATION |
| RapidPulseTM Aspiration System | Accident vasculaire cérébral | Non applicable | NCT06029491 | TURBO — Thrombectomy Using Pulsed Aspiration for Reperfusion of Brain Occlusions | RECRUITING |
| Bodyport Cardiac Scale | Maladie rénale chronique | À vérifier | NCT07059962 | Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD) | RECRUITING |
| delandistrogene moxeparvovec | Myopathies | À vérifier | NCT06270719 | ENDURE — An Observational Study Comparing Delandistrogene Moxeparvovec (ELEVIDYS) With Standard of Care in Participants With Duchenne Muscular Dystrophy | ENROLLING_BY_INVITATION |
| Empagliflozin | Maladie rénale chronique | Phase 3 | NCT07107945 | A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids) | ACTIVE_NOT_RECRUITING |
| Surgical management | Accident vasculaire cérébral | Non applicable | NCT06870812 | REACH — Rapid Evacuation and Access of Cerebral Hemorrhage Trial | RECRUITING |
| Flow diversion | Accident vasculaire cérébral | Non applicable | NCT07143019 | PIANO — The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms | RECRUITING |
| WATCHMAN FLX LAAC Device | Accident vasculaire cérébral | Non applicable | NCT04394546 | CHAMPION-AF Clinical Trial | ACTIVE_NOT_RECRUITING |
| Colchicine 0.5 MG Oral Tablet | Maladie coronarienne | Phase 3 | NCT04774159 | LEADER-PAD — Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk | RECRUITING |
| Panitumumab-IRDye800 | Cancer | Phase 1 | NCT07493447 | Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures | RECRUITING |
| Nivo800 | Cancer | Phase 1 | NCT07460765 | Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC) | RECRUITING |
| XEN1101 | Épilepsie | Phase 3 | NCT05716100 | A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) | RECRUITING |
| SPN-817 | Épilepsie | Phase 2 | NCT06798896 | RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures | RECRUITING |
| Theophylline | SEP | Phase 2 | NCT04551170 | Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old | ACTIVE_NOT_RECRUITING |
| TAR-200 | Cancer | Phase 3 | NCT06211764 | SunRISe-5 — A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG) | ACTIVE_NOT_RECRUITING |
| cemacabtagene ansegedleucel | SEP | Phase 2 | NCT06500273 | ALPHA3 — Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL | RECRUITING |
| Nicotine Transdermal Patch | Alzheimer | Phase 2 | NCT02720445 | Memory Improvement Through Nicotine Dosing (MIND) Study | COMPLETED |
| Theophylline ER | SEP | Phase 2 | NCT04240821 | Theophylline for Treatment of Pseudohypoparathyroidism | ENROLLING_BY_INVITATION |
| Ocrelizumab | SEP | Phase 4 | NCT04377555 | Prospective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With Ocrelizumab | COMPLETED |
| AADvac1 | Alzheimer | Phase 2 | NCT07167966 | ATP — Alzheimer's Tau Platform: Regimen A - AADvac1 | ENROLLING_BY_INVITATION |
| AADvac1 | Alzheimer | Phase 2 | NCT06957418 | ATP — Alzheimer's Tau Platform: Master Protocol | RECRUITING |
| Baricitinib 4 MG | Alzheimer | Phase 3 | NCT05858515 | REVERSE-LC — REVERSE-Long COVID-19 With Baricitinib Study | WITHDRAWN |
| RO7046015 | Parkinson | Phase 2 | NCT03100149 | PASADENA — A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease | ACTIVE_NOT_RECRUITING |
| Inavolisib | Cancer | Phase 3 | NCT06790693 | INAVO123 — A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer | RECRUITING |
| BHV-7000 | Épilepsie | Phase 2/3 | NCT06132893 | RISE 2 — A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy | ACTIVE_NOT_RECRUITING |
| Semaglutide (Rybelsus®) | Myopathies | Phase 1/2 | NCT07642635 | Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular Dystrophy | NOT_YET_RECRUITING |
| VMAP — Vanderbilt Memory and Aging Project | Alzheimer | À vérifier | NCT05372159 | VMAP — Vanderbilt Memory and Aging Project | ACTIVE_NOT_RECRUITING |
| bemdaneprocel | Parkinson | Phase 3 | NCT06944522 | exPDite-2 — A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease | RECRUITING |
| Prasinezumab | Parkinson | Phase 3 | NCT07174310 | PARAISO — A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease | RECRUITING |
| ASSESS ALL ALS Study | Sclérose latérale amyotrophique | À vérifier | NCT06578195 | ASSESS ALL ALS Study | RECRUITING |
| SGLT-2 inhibitor | Myopathies | Phase 1 | NCT07172971 | CHERISH — Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy | RECRUITING |
| Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials | Myopathies | À vérifier | NCT07674758 | Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials | RECRUITING |
| Litifilimab | Lupus | Phase 2/3 | NCT05531565 | AMETHYST — A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus | ACTIVE_NOT_RECRUITING |
| RAP-219 | Épilepsie | Phase 3 | NCT07594119 | FOCUS 2 — Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures | RECRUITING |
| EEG | Épilepsie | Non applicable | NCT06934356 | Subcortical Arousal in Perceptual Awareness | RECRUITING |
| XEN1101 | Épilepsie | Phase 3 | NCT05718817 | X-TOLE4 — An Open-label Study of XEN1101 in Epilepsy | ENROLLING_BY_INVITATION |
| Midodrine | Parkinson | Phase 1 | NCT04620382 | Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients | COMPLETED |
| Pimavanserin | Parkinson | Phase 4 | NCT05357612 | Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases | RECRUITING |
| Natalizumab 300 MG in 15 ML Injection | SEP | Phase 4 | NCT05177718 | Natalizumab and Chronic Inflammation | TERMINATED |
| Trimethaphan | Hypertension | Phase 1 | NCT02726711 | Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic | ACTIVE_NOT_RECRUITING |
| Renal Denervation (Symplicity Spyral™) | Hypertension | Non applicable | NCT05198674 | SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN | ACTIVE_NOT_RECRUITING |
| Zilucoplan | Sclérose latérale amyotrophique | Phase 2/3 | NCT04297683 | HEALEY ALS Platform Trial - Master Protocol | ACTIVE_NOT_RECRUITING |
| Fenebrutinib | SEP | Phase 3 | NCT04544449 | FENtrepid — A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis | ACTIVE_NOT_RECRUITING |
| eculizumab | Myasthénie | Phase 2 | NCT00727194 | Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis | TERMINATED |